(Q64352320)
Statements
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects With Progressive Multiple Sclerosis (English)
0 references
November 2013
0 references
May 2017
0 references
255
0 references
21 year
0 references
65 year
0 references